TLR6
Toll-like receptor 6
Also known as: CD286, TLR6_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y2C9
- Gene
- TLR6
- Ensembl
- ENSG00000174130
- Chromosome
- 4
- Canonical length
- 796 aa
- Protein class
- CD markers, Predicted membrane proteins
- Subcellular location
- Endoplasmic reticulum
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This receptor functionally interacts with toll-like receptor 2 to mediate cellular response to bacterial lipoproteins. A Ser249Pro polymorphism in the extracellular domain of the encoded protein may be associated with an increased of asthma is some populations.[provided by RefSeq, Jan 2011]
Canonical amino-acid sequenceUniProt
796 residues, UniProt reviewed canonical sequence.
>Q9Y2C9|TLR6
1 MTKDKEPIVK SFHFVCLMII IVGTRIQFSD GNEFAVDKSK RGLIHVPKDL PLKTKVLDMS
61 QNYIAELQVS DMSFLSELTV LRLSHNRIQL LDLSVFKFNQ DLEYLDLSHN QLQKISCHPI
121 VSFRHLDLSF NDFKALPICK EFGNLSQLNF LGLSAMKLQK LDLLPIAHLH LSYILLDLRN
181 YYIKENETES LQILNAKTLH LVFHPTSLFA IQVNISVNTL GCLQLTNIKL NDDNCQVFIK
241 FLSELTRGST LLNFTLNHIE TTWKCLVRVF QFLWPKPVEY LNIYNLTIIE SIREEDFTYS
301 KTTLKALTIE HITNQVFLFS QTALYTVFSE MNIMMLTISD TPFIHMLCPH APSTFKFLNF
361 TQNVFTDSIF EKCSTLVKLE TLILQKNGLK DLFKVGLMTK DMPSLEILDV SWNSLESGRH
421 KENCTWVESI VVLNLSSNML TDSVFRCLPP RIKVLDLHSN KIKSVPKQVV KLEALQELNV
481 AFNSLTDLPG CGSFSSLSVL IIDHNSVSHP SADFFQSCQK MRSIKAGDNP FQCTCELREF
541 VKNIDQVSSE VLEGWPDSYK CDYPESYRGS PLKDFHMSEL SCNITLLIVT IGATMLVLAV
601 TVTSLCIYLD LPWYLRMVCQ WTQTRRRARN IPLEELQRNL QFHAFISYSE HDSAWVKSEL
661 VPYLEKEDIQ ICLHERNFVP GKSIVENIIN CIEKSYKSIF VLSPNFVQSE WCHYELYFAH
721 HNLFHEGSNN LILILLEPIP QNSIPNKYHK LKALMTQRTY LQWPKEKSKR GLFWANIRAA
781 FNMKLTLVTE NNDVKSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TLR6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 11 nTPM
- lymph node: 8.2 nTPM
- appendix: 8.1 nTPM
- spleen: 7.8 nTPM
- bone marrow: 3.8 nTPM
- small intestine: 3.7 nTPM
Single-cell type
- neutrophils: 1.9 nCPM
- kupffer cells: 1 nCPM
- lacrimal acinar cells: 0.9 nCPM
- microglia: 0.8 nCPM
- thymocytes: 0.8 nCPM
- macrophages: 0.5 nCPM
Immune cell
- neutrophil: 11 nTPM
- classical monocyte: 2.4 nTPM
- intermediate monocyte: 2 nTPM
- memory B-cell: 1.8 nTPM
- myeloid DC: 1.5 nTPM
- non-classical monocyte: 1.1 nTPM
Brain region
- white matter: 9.6 nTPM
- medulla oblongata: 7.2 nTPM
- thalamus: 7 nTPM
- spinal cord: 6.5 nTPM
- pons: 6.3 nTPM
- midbrain: 5.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.85
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.94
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- activation of NF-kappaB-inducing kinase activity
- cellular response to amyloid-beta
- cellular response to diacyl bacterial lipopeptide
- cellular response to oxidised low-density lipoprotein particle stimulus
- defense response to bacterium
- detection of diacyl bacterial lipopeptide
- immune response
- inflammatory response
- innate immune response
- microglial cell activation
- MyD88-dependent toll-like receptor signaling pathway
- negative regulation of interleukin-8 production
- negative regulation of toll-like receptor 2 signaling pathway
- negative regulation of tumor necrosis factor production
- nitric oxide metabolic process
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of cytokine production involved in inflammatory response
- positive regulation of extrinsic apoptotic signaling pathway
- positive regulation of gene expression
- positive regulation of inflammatory response
- positive regulation of interleukin-1 beta production
- positive regulation of interleukin-6 production
- positive regulation of JUN kinase activity
- positive regulation of macrophage activation
- positive regulation of nitric oxide biosynthetic process
- positive regulation of NLRP3 inflammasome complex assembly
- positive regulation of reactive oxygen species biosynthetic process
- signal transduction
- toll-like receptor signaling pathway
- toll-like receptor TLR6:TLR2 signaling pathway
- TRIF-dependent toll-like receptor signaling pathway
Molecular functions
- amyloid-beta binding
- identical protein binding
- lipopeptide binding
- protein heterodimerization activity
- signaling receptor activity
- signaling receptor binding
- Toll-like receptor 2 binding
- transmembrane signaling receptor activity
- diacyl lipopeptide binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Toll/interleukin-1 receptor homology (TIR) domain
- Cysteine-rich flanking region, C-terminal
- Leucine-rich repeat
- Leucine-rich repeat, typical subtype
- Toll-like receptor
- Leucine-rich repeat domain superfamily
- Toll/interleukin-1 receptor homology (TIR) domain superfamily
- Leucine rich repeat C-terminal domain
- TIR domain
- Leucine rich repeat
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TLR6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TLR6 as an antibody target. Whether an autoantibody or antibody against TLR6 could matter depends on whether native TLR6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TLR6 is annotated at the cell surface, where native TLR6 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TLR6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...